Improving Metabolic Assessments in Type 1 Diabetes Mellitus Clinical Trials
Diabetes Mellitus, Type 1
About this trial
This is an interventional diagnostic trial for Diabetes Mellitus, Type 1 focused on measuring Type 1 Diabetes Study Group, TrialNet, type 1 diabetes, juvenile onset diabetes
Eligibility Criteria
Informed consent obtained from participants (over 12 years of age) and parents (for participants below 18 years of age). Assent is obtained from younger children. Age 8 - 35 years at the time of inclusion Body weight > 30 kg Type 1 diabetes defined by: ADA (American Diabetes Association) criteria or judgment of physician Duration of diabetes: 1 month to 3* years (*The TrialNet Coordinating Center will monitor fasting C-peptide levels as they are reported to ensure that a wide range of values is included. This review may result in widening the duration of diabetes window to allow for subjects with low C-peptide). Must maintain good glycemic control Be willing to travel to a TrialNet Clinical Center for a minimum of four separate visits that are spaced 3-10 days apart, and be willing to complete the study within a six week period. Exclusion Criteria: Actual treatment with drugs influencing beta cell function (e.g. oral hypoglycaemic agents, beta-2-receptor agonists) Actual treatment with drugs influencing insulin sensitivity (e.g. steroids) Significant concomitant disease likely to interfere with glucose metabolism (e.g. febrile illness within the prior 3 days) Expected poor compliance If a female of child-bearing age, currently pregnant or not using a form of birth control Any other condition that by the judgement of the investigator may be potentially harmful to the patients
Sites / Locations
- Children's Hospital Los Angeles
- University of California San Francisco
- Stanford University Medical Center
- Barbara Davis Center for Childhood Diabetes, University of Colorado
- University of Florida
- University of Miami School of Medicine
- Riley Hospital for Children, Indiana University
- Joslin Diabetes Center/ Children's Hospital Boston
- University of Minnesota
- Naomi Berrie Diabetes Center, Columbia University
- Children's Hospital of Pittsburgh of UPMC
- University of Texas Medical Center at Dallas
- Benaroya Research Institute
- Walter and Eliza Hall Institute of Medical Research
- University of Toronto
- University of Turku
- Vita-Salute San Raffaele University
- University of Bristol